Migraine Prophylaxis: Recommended Treatments
First-Line Prophylactic Medications
Beta-blockers, topiramate, and candesartan are the first-line medications for migraine prophylaxis, with propranolol (80-240 mg/day) and timolol (20-30 mg/day) having the strongest evidence for efficacy. 1
- Propranolol is FDA-approved for migraine prophylaxis with robust clinical trial data demonstrating effectiveness in reducing migraine frequency 1, 2
- Timolol (20-30 mg/day) represents another beta-blocker option with strong evidence 1
- Alternative beta-blockers including atenolol, bisoprolol, or metoprolol can be used when propranolol or timolol are not tolerated 1
- Topiramate (100 mg/day, typically 50 mg twice daily) is recommended as first-line therapy, with clinical trials showing 46% of patients achieving at least 50% reduction in migraine frequency 1, 3, 4
- Candesartan is particularly useful for patients with comorbid hypertension 1
Second-Line Prophylactic Medications
When first-line agents fail or are contraindicated, move to second-line options:
- Amitriptyline (30-150 mg/day) is particularly effective in patients with mixed migraine and tension-type headache 1
- Sodium valproate (800-1500 mg/day) or divalproex sodium (500-1500 mg/day) are effective but strictly contraindicated in women of childbearing potential due to teratogenic effects 1
- Flunarizine is an effective second-line option where available 1
Third-Line Medications: CGRP Monoclonal Antibodies
CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) should be considered when other preventive treatments have failed or are contraindicated. 1
- These agents require 3-6 months of treatment before efficacy can be properly assessed 1
- They represent a significant advancement for patients who have exhausted traditional prophylactic options 1
Indications for Preventive Therapy
Initiate prophylaxis when patients meet any of these criteria:
- ≥2 migraine attacks per month with disability lasting ≥3 days per month 1, 5
- Using abortive medication more than twice per week to avoid medication overuse headache 1, 5
- Contraindications to or failure of acute treatments 1, 5
- Uncommon migraine conditions (hemiplegic migraine, prolonged aura, migrainous infarction) 1
Implementation Strategy
Start with a low dose and titrate slowly until clinical benefits are achieved or side effects limit further increases, allowing an adequate trial period of 2-3 months before determining efficacy. 1, 5
- For topiramate, titrate by 25 mg weekly to target dose of 100 mg/day 3, 4
- For propranolol, typical dosing ranges from 80-240 mg/day 1, 2
- Use headache diaries to track attack frequency, severity, duration, disability, treatment response, and adverse effects 1, 5
- Monitor for medication overuse, which can interfere with preventive treatment 1, 5
Duration of Therapy
Consider pausing preventive treatment after 6-12 months of successful therapy to determine if it can be discontinued. 1
- Calculate the percentage reduction in monthly migraine days as a useful measure to quantify success 1
- Taper medications gradually rather than stopping abruptly 1
Critical Pitfalls to Avoid
- Failing to recognize medication overuse headache from frequent use of acute medications (>2 days/week), which undermines prophylactic efficacy 1, 5
- Inadequate trial duration (less than 2-3 months for oral agents; less than 3-6 months for CGRP antibodies) before declaring treatment failure 1
- Starting with too high a dose, leading to poor tolerability and discontinuation 1
- Prescribing valproate to women of childbearing potential without addressing contraception, given severe teratogenic risks 1
Non-Pharmacological Adjuncts
Consider these evidence-based options as adjuncts or alternatives when medications are contraindicated:
- Neuromodulatory devices can serve as adjuncts or stand-alone treatments 1
- Biobehavioral therapy (biofeedback, relaxation training) has demonstrated efficacy 1
- Acupuncture may be considered, though not superior to sham acupuncture in controlled trials 1
Special Considerations for Topiramate
While topiramate is effective, be aware of its adverse effect profile:
- Most common side effects include paresthesia (53%), nausea, dizziness, fatigue, anorexia, and cognitive disturbances 3, 4, 6
- Weight loss is common and may be beneficial for overweight patients 3
- The 100 mg/day dose provides optimal balance of efficacy and tolerability; 200 mg/day offers no additional benefit but increases side effects 3, 4
- Topiramate is particularly appropriate for patients concerned about weight gain or those with coexisting epilepsy 3